Genetic Technologies Ltd. ADR (GENE): Price and Financial Metrics
GENE Price/Volume Stats
| Current price | $0.77 | 52-week high | $3.77 |
| Prev. close | $0.78 | 52-week low | $0.67 |
| Day low | $0.77 | Volume | 22,600 |
| Day high | $0.79 | Avg. volume | 42,570 |
| 50-day MA | $0.81 | Dividend yield | N/A |
| 200-day MA | $1.74 | Market Cap | 3.37M |
GENE Stock Price Chart Interactive Chart >
Genetic Technologies Ltd. ADR (GENE) Company Bio
Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
GENE Price Returns
| 1-mo | N/A |
| 3-mo | -14.45% |
| 6-mo | N/A |
| 1-year | -78.00% |
| 3-year | -93.71% |
| 5-year | -92.45% |
| YTD | -67.92% |
| 2023 | -48.39% |
| 2022 | -50.53% |
| 2021 | -47.78% |
| 2020 | 80.90% |
| 2019 | -9.54% |
Continue Researching GENE
Want to see what other sources are saying about Genetic Technologies Ltd's financials and stock price? Try the links below:Genetic Technologies Ltd (GENE) Stock Price | Nasdaq
Genetic Technologies Ltd (GENE) Stock Quote, History and News - Yahoo Finance
Genetic Technologies Ltd (GENE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...